295 related articles for article (PubMed ID: 15389275)
1. Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study.
Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Lai WW; Fan DS; Chan WM
Eye (Lond); 2005 Aug; 19(8):885-90. PubMed ID: 15389275
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
4. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
5. Phacoemulsification with intravitreal bevacizumab and triamcinolone acetonide injection in diabetic patients with clinically significant macular edema and cataract.
Akinci A; Muftuoglu O; Altınsoy A; Ozkılıc E
Retina; 2011 Apr; 31(4):755-8. PubMed ID: 21124251
[TBL] [Abstract][Full Text] [Related]
6. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
7. The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.
Habib MS; Cannon PS; Steel DH
BMC Ophthalmol; 2005 Jun; 5():15. PubMed ID: 15972106
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.
Konstantopoulos A; Williams CP; Luff AJ
Eye (Lond); 2008 Feb; 22(2):219-22. PubMed ID: 17016463
[TBL] [Abstract][Full Text] [Related]
9. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
10. Cataract surgery after intravitreal injection of triamcinolone acetonide.
Jonas JB; Kreissig I; Degenring RF
Eye (Lond); 2004 Apr; 18(4):361-4. PubMed ID: 15069430
[TBL] [Abstract][Full Text] [Related]
11. Effect of a single intraoperative sub-Tenon injection of triamcinolone acetonide on the progression of diabetic retinopathy and visual outcomes after cataract surgery.
Kim SY; Yang J; Lee YC; Park YH
J Cataract Refract Surg; 2008 May; 34(5):823-6. PubMed ID: 18471640
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
Dada T; Dhawan M; Garg S; Nair S; Mandal S
J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation.
Negi AK; Vernon SA; Lim CS; Owen-Armstrong K
Eye (Lond); 2005 Jul; 19(7):747-51. PubMed ID: 15359268
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
16. Improved visual acuity and macular thickness 1 week after intravitreal triamcinolone for diabetic macular oedema.
Islam MS; Negi A; Vernon SA
Eye (Lond); 2005 Dec; 19(12):1325-7. PubMed ID: 15578081
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
[TBL] [Abstract][Full Text] [Related]
18. Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.
Akinci A; Batman C; Ozkilic E; Altinsoy A
Retina; 2009; 29(10):1432-5. PubMed ID: 19898181
[TBL] [Abstract][Full Text] [Related]
19. The transient efficacy of a single intravitreal triamcinolone acetonide injection for diabetic macular edema.
Desatnik H; Habot-Wilner Z; Alhalel A; Moroz I; Glovinsky J; Moisseiev J
Isr Med Assoc J; 2006 Jun; 8(6):383-7. PubMed ID: 16833165
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.
Takata C; Messias A; Folgosa MS; Lucena LR; Lucena DR; Scott IU; Jorge R
Retina; 2010 Apr; 30(4):562-9. PubMed ID: 20182403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]